Kezheng Peng

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
It has been demonstrated that mTOR/p70S6K pathway was abnormally activated in many cancers and rapamycin and its analogs can restrain tumor growth through inhibiting this pathway, but some tumors including esophageal squamous cell carcinoma (ESCC) appear to be insensitive to rapamycin in recent studies. In the present study, we explored the measures to(More)
  • 1